Contract 75N93023P01217
Stemcell Technologies Inc · Department Of Health And Human Services · September 6, 2023
Stemcell Technologies Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 6, 2023 for $100,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Kent, WA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N93023P01217
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Drugs And Biologicals, Veterinary Use
- Place of performance
- Kent, WA
- First action
- September 6, 2023
Description
EASYSEP NEGATIVE HUMAN CD4 KITS FROM STEMCELL TECHNOLOGIES INC. (AMBIS #2174473)
Modification timeline
-
September 6, 2023Base award$99.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93023P01217?
Contract 75N93023P01217 is a federal contract awarded to Stemcell Technologies Inc by Department Of Health And Human Services on September 6, 2023 for $100,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N93023P01217?
Stemcell Technologies Inc won contract 75N93023P01217 from Department Of Health And Human Services.
How much is contract 75N93023P01217 worth?
Contract 75N93023P01217 has obligated $100,000 to date.